Entry
Name
Glutamatergic synapse - Homo sapiens (human)
Description
Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system(CNS). Glutamate is packaged into synaptic vesicles in the presynaptic terminal. Once released into the synaptic cleft, glutamate acts on postsynaptic ionotropic glutamate receptors (iGluRs) to mediate fast excitatory synaptic transmission. Glutamate can also act on metabotropic glutamate receptors (mGluRs) and exert a variety of modulatory effects through their coupling to G proteins and the subsequent recruitment of second messenger systems. Presynaptically localized Group II and Group III mGluRs are thought to represent the classical inhibitory autoreceptor mechanism that suppresses excess glutamate release. After its action on these receptors, glutamate can be removed from the synaptic cleft by EAATs located either on the presynaptic terminal, neighboring glial cells, or the postsynaptic neuron. In glia, glutamate is converted to glutamine, which is then transported back to the presynaptic terminal and converted back to glutamate.
Class
Organismal Systems; Nervous system
BRITE hierarchy
Pathway map
Ortholog table
Network
Element
N00953 mGluR1-TRPC3 signaling pathway
N00967 VGCC-Ca2+ -apoptotic pathway
N00984 mGluR5-Ca2+ -apoptotic pathway
Drug
D00537 Topiramate (JAN/USP/INN)
D00711 Ketamine hydrochloride (JP18/USP)
D00774 Orphenadrine citrate (USP)
D00777 Amantadine hydrochloride (JP18/USP)
D00848 Dextromethorphan hydrobromide (USP)
D02102 Methadone hydrochloride (JAN/USP)
D02599 Orphenadrine hydrochloride
D02780 Acamprosate calcium (JAN/USAN)
D02973 Aptiganel hydrochloride (USAN)
D03679 Delucemine hydrochloride (USAN)
D03744 Dextromethorphan polistirex (USAN)
D03746 Dextrorphan hydrochloride (USAN)
D03878 Dizocilpine maleate (USAN)
D04905 Memantine hydrochloride (JAN/USP)
D05145 Neramexane mesylate (USAN)
D05453 Phencyclidine hydrochloride (USAN)
D05714 Remacemide hydrochloride (USAN)
D06146 Tiletamine hydrochloride (USP)
D06204 Traxoprodil mesylate (USAN)
D08122 Levomethadone hydrochloride
D09008 Talaglumetad hydrochloride (USAN)
D09917 Latrepirdine (USAN/INN)
D09918 Latrepirdine dihydrochloride (USAN)
D09949 Pomaglumetad methionil (USAN)
D10107 Dasolampanel (USAN/INN)
D10108 Dasolampanel etibutil (USAN)
D10109 Dasolampanel etibutil tosylate (USAN)
D10627 Esketamine hydrochloride (JAN/USAN)
D10780 Perampanel hydrate (JAN)
D10896 Pomaglumetad methionil (INN)
D11415 Troriluzole hydrochloride (USAN)
D12215 Esmethadone hydrochloride (USAN)
Other DBs
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
81539 SLC38A1; solute carrier family 38 member 1 [KO:K14990 ]
54407 SLC38A2; solute carrier family 38 member 2 [KO:K14207 ]
57084 SLC17A6; solute carrier family 17 member 6 [KO:K12302 ]
246213 SLC17A8; solute carrier family 17 member 8 [KO:K12302 ]
57030 SLC17A7; solute carrier family 17 member 7 [KO:K12302 ]
2897 GRIK1; glutamate ionotropic receptor kainate type subunit 1 [KO:K05201 ]
2898 GRIK2; glutamate ionotropic receptor kainate type subunit 2 [KO:K05202 ]
2899 GRIK3; glutamate ionotropic receptor kainate type subunit 3 [KO:K05203 ]
2900 GRIK4; glutamate ionotropic receptor kainate type subunit 4 [KO:K05204 ]
2901 GRIK5; glutamate ionotropic receptor kainate type subunit 5 [KO:K05205 ]
2890 GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197 ]
2891 GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198 ]
2892 GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199 ]
2893 GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200 ]
2902 GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208 ]
2903 GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209 ]
2904 GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210 ]
2905 GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211 ]
2906 GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212 ]
116443 GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213 ]
116444 GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214 ]
5534 PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268 ]
5535 PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268 ]
1742 DLG4; discs large MAGUK scaffold protein 4 [KO:K11828 ]
85358 SHANK3; SH3 and multiple ankyrin repeat domains 3 [KO:K15009 ]
50944 SHANK1; SH3 and multiple ankyrin repeat domains 1 [KO:K15009 ]
22941 SHANK2; SH3 and multiple ankyrin repeat domains 2 [KO:K15009 ]
9762 LZTS3; leucine zipper tumor suppressor family member 3 [KO:K26472 ]
7220 TRPC1; transient receptor potential cation channel subfamily C member 1 [KO:K04964 ]
2911 GRM1; glutamate metabotropic receptor 1 [KO:K04603 ]
2915 GRM5; glutamate metabotropic receptor 5 [KO:K04604 ]
3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958 ]
3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959 ]
3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960 ]
2912 GRM2; glutamate metabotropic receptor 2 [KO:K04605 ]
2913 GRM3; glutamate metabotropic receptor 3 [KO:K04606 ]
2914 GRM4; glutamate metabotropic receptor 4 [KO:K04607 ]
2916 GRM6; glutamate metabotropic receptor 6 [KO:K04608 ]
2917 GRM7; glutamate metabotropic receptor 7 [KO:K04609 ]
2918 GRM8; glutamate metabotropic receptor 8 [KO:K04610 ]
2770 GNAI1; G protein subunit alpha i1 [KO:K04630 ]
2773 GNAI3; G protein subunit alpha i3 [KO:K04630 ]
2771 GNAI2; G protein subunit alpha i2 [KO:K04630 ]
2775 GNAO1; G protein subunit alpha o1 [KO:K04534 ]
2790 GNG10; G protein subunit gamma 10 [KO:K04545 ]
2791 GNG11; G protein subunit gamma 11 [KO:K04546 ]
2792 GNGT1; G protein subunit gamma transducin 1 [KO:K04548 ]
2793 GNGT2; G protein subunit gamma transducin 2 [KO:K04549 ]
3760 KCNJ3; potassium inwardly rectifying channel subfamily J member 3 [KO:K04997 ]
773 CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344 ]
6506 SLC1A2; solute carrier family 1 member 2 [KO:K05613 ]
6512 SLC1A7; solute carrier family 1 member 7 [KO:K05618 ]
6505 SLC1A1; solute carrier family 1 member 1 [KO:K05612 ]
6511 SLC1A6; solute carrier family 1 member 6 [KO:K05617 ]
775 CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850 ]
776 CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851 ]
6507 SLC1A3; solute carrier family 1 member 3 [KO:K05614 ]
10991 SLC38A3; solute carrier family 38 member 3 [KO:K13576 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
Reference
Authors
Niswender CM, Conn PJ
Title
Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Journal
Reference
Authors
Ferraguti F, Crepaldi L, Nicoletti F
Title
Metabotropic glutamate 1 receptor: current concepts and perspectives.
Journal
Reference
Authors
Hermans E, Challiss RA
Title
Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.
Journal
Reference
Authors
Kim CH, Lee J, Lee JY, Roche KW
Title
Metabotropic glutamate receptors: phosphorylation and receptor signaling.
Journal
Reference
Authors
Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE
Title
Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.
Journal
Reference
Authors
Sanacora G, Zarate CA, Krystal JH, Manji HK
Title
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
Journal
Reference
Authors
Gass JT, Olive MF
Title
Glutamatergic substrates of drug addiction and alcoholism.
Journal
Reference
Authors
Palmada M, Centelles JJ
Title
Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain.
Journal
Reference
Authors
Schoepp DD
Title
Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.
Journal
J Pharmacol Exp Ther 299:12-20 (2001)
Reference
Authors
de Jong AP, Verhage M
Title
Presynaptic signal transduction pathways that modulate synaptic transmission.
Journal
Reference
Authors
Pinheiro PS, Mulle C
Title
Presynaptic glutamate receptors: physiological functions and mechanisms of action.
Journal
Reference
Authors
Byrnes KR, Loane DJ, Faden AI
Title
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.
Journal
Reference
Authors
Conti F, Weinberg RJ
Title
Shaping excitation at glutamatergic synapses.
Journal
Reference
Authors
Sheng M, Kim MJ
Title
Postsynaptic signaling and plasticity mechanisms.
Journal
Related pathway
KO pathway